Squarepoint Ops LLC - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 37 filers reported holding SEELOS THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$72,000
-53.5%
29,690
-4.4%
0.00%
-100.0%
Q1 2021$155,000
-39.5%
31,060
-80.8%
0.00%
-50.0%
Q4 2020$256,000
+2744.4%
161,804
+831.3%
0.00%
Q1 2020$9,000
-67.9%
17,374
-18.0%
0.00%
Q4 2019$28,000
+33.3%
21,200
-9.1%
0.00%
Q3 2019$21,000
-66.7%
23,330
-18.5%
0.00%
-100.0%
Q2 2019$63,00028,6290.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
GENDELL JEFFREY L 4,908,725$5,056,0000.66%
Uniplan Investment Counsel, Inc. 2,485,327$2,559,0000.20%
Oasis Management Co Ltd. 850,000$876,0000.15%
AdvisorShares Investments LLC 470,151$484,0000.13%
1492 Capital Management LLC 99,819$103,0000.07%
Sovereign Financial Group, Inc. 75,000$77,0000.03%
ASSET MANAGEMENT CORP /IL/ /ADV 45,500$47,0000.03%
MAI Capital Management 1,230,810$1,268,0000.02%
GSA CAPITAL PARTNERS LLP 137,266$141,0000.02%
FORTEM FINANCIAL GROUP, LLC 20,000$21,0000.02%
View complete list of SEELOS THERAPEUTICS INC shareholders